𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunopathogenesis of hepatitis B e antigen negative chronic hepatitis B infection

✍ Scribed by Stephanos J Hadziyannis; Dimitrios Vassilopoulos

Book ID
114144349
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
172 KB
Volume
52
Category
Article
ISSN
0166-3542

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis B e antigen–negative chronic h
Hepatitis B e antigen–negative chronic hepatitis b in Hong Kong
✍ Henry L. Y. Chan; Nancy W. Y. Leung; Munira Hussain; May L. Wong; Anna S. F. Lok 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 1 views

Hepatitis B e antigen-negative chronic hepatitis B (eϪCHB) has been reported in Asia but its prevalence and clinical significance have not been determined. The aims of this study were to determine the prevalence of eϪCHB in Hong Kong and the frequency of precore and core promoter mutations in these

Serum hepatitis B virus-DNA cutoff level
Serum hepatitis B virus-DNA cutoff levels in hepatitis B e antigen–negative chronic hepatitis B virus infection
✍ George V. Papatheodoridis; Emanuel K. Manesis; Spilios Manolakopoulos; Athanasio 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB 👁 2 views

Commitment of bone marrow cells to hepatic stellate cells in mouse. J Hepatol 2004;40:255-260. 6. Kisseleva T, Uchinami H, Feirt N, Quintana-Bustamante O, Segovia JC, Schwabe RF, et al. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol 2006;45:429-438. 7. Magnes

Hepatitis B virus DNA prediction rules f
Hepatitis B virus DNA prediction rules for hepatitis B e antigen–negative chronic hepatitis B
✍ Jordan J. Feld; Melissa Ayers; Dahlia El-Ashry; Tony Mazzulli; Raymond Tellier; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 672 KB

After hepatitis B e antigen (HBeAg) seroconversion, hepatitis B may become inactive or progress to HBeAg-negative hepatitis with persistent or intermittent alanine aminotransferase (ALT) elevation. The aim of this study was to prospectively identify factors predictive of the clinical course in HBeAg